Johnson & Johnson (NYSE: JNJ) Q2 2021 earnings call dated Jul. 21, 2021
Corporate Participants:
Christopher DelOrefice — Vice President, Investor Relations
Joseph J. Wolk — Executive Vice President, Chief Financial Officer
Jennifer Taubert — Executive Vice President, Worldwide Chairman, Pharmaceuticals
Thibaut Mongon — Executive Vice President, Worldwide Chairman, Consumer Health
Ashley McEvoy — Executive Vice President, Worldwide Chairman, Medical Devices
Paul Stoffels — Vice Chairman of the Executive Committee and Chief Scientific Officer
Analysts:
Louise Chen — Cantor Fitzgerald Securities — Analyst
Larry Biegelsen — Wells Fargo Securities LLC — Analyst
Chris Schott — J.P. Morgan Securities LLC — Analyst
Bob Hopkins — BofA Securities, Inc. — Analyst
Joshua Jennings — Cowen and Company — Analyst
Terence Flynn — Goldman Sachs & Co. LLC — Analyst
Matt Miksic — Credit Suisse Securities (USA) LLC — Analyst
Joanne Wuensch — Citi — Analyst
Jayson Bedford — Raymond James Financial Inc. — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Earnings Preview: What to look for when Netflix (NFLX) reports Q4 2025 results
Netflix, Inc. (NASDAQ: NFLX) is expected to report Q4 results on January 20, amid expectations for strong revenue and earnings growth. The company is navigating a shifting streaming landscape where
What to look for when United Airlines (UAL) reports its Q4 2025 earnings results
Shares of United Airlines (NASDAQ: UAL) stayed red on Thursday. The stock has gained 15% over the past three months. The airline is scheduled to report its earnings results for
Infographic: How Constellation Brands (STZ) performed in Q3 2026
Constellation Brands, Inc. (NYSE: STZ) reported net sales of $2.22 billion for the third quarter of 2026, down 10% year-over-year. Organic net sales were down 2%. Net income attributable to
Listen On
